{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:56:30Z","timestamp":1790772990588,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":80,"publisher":"Springer US","isbn-type":[{"value":"9781071654750","type":"print"},{"value":"9781071654767","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5476-7_3","type":"book-chapter","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:33:53Z","timestamp":1790764433000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers"],"prefix":"10.1007","author":[{"given":"Rida","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"7","key":"3_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/bies.200900112","volume":"32","author":"FF Costa","year":"2010","unstructured":"Costa FF (2010) Non-coding RNAs: meet thy masters. BioEssays 32(7):599\u2013608","journal-title":"BioEssays"},{"issue":"4","key":"3_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli M-T, Viereck J et al. (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96(4):1297\u20131325","journal-title":"Physiol Rev"},{"issue":"8","key":"3_CR3","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.3390\/ijms140816010","volume":"14","author":"AQ Gomes","year":"2013","unstructured":"Gomes AQ, Nolasco S, Soares H (2013) Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci 14(8):16010\u201316039","journal-title":"Int J Mol Sci"},{"issue":"25","key":"3_CR4","doi-asserted-by":"publisher","first-page":"37944","DOI":"10.18632\/oncotarget.9272","volume":"7","author":"P Krishnan","year":"2016","unstructured":"Krishnan P, Ghosh S, Graham K et al. (2016) Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer. Oncotarget 7(25):37944","journal-title":"Oncotarget"},{"issue":"2","key":"3_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2012.07.033","volume":"48","author":"Q-F Yin","year":"2012","unstructured":"Yin Q-F, Yang L, Zhang Y et al. (2012) Long non-coding RNAs with snoRNA ends. Mol Cell 48(2):219\u2013230","journal-title":"Mol Cell"},{"issue":"2","key":"3_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/wrna.1324","volume":"7","author":"PY Ho","year":"2016","unstructured":"Ho PY, Yu AM (2016) Bioengineering of non-coding RNAs for research agents and therapeutics. Wiley Interdiscip Rev: RNA 7(2):186\u2013197","journal-title":"Wiley Interdiscip Rev: RNA"},{"issue":"12","key":"3_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12):861","journal-title":"Nat Rev Genet"},{"issue":"12","key":"3_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nrm.2016.126","volume":"17","author":"JM Engreitz","year":"2016","unstructured":"Engreitz JM, Ollikainen N, Guttman M (2016) Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol 17(12):756","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10(3):155","journal-title":"Nat Rev Genet"},{"issue":"D1","key":"3_CR10","doi-asserted-by":"publisher","first-page":"D135","DOI":"10.1093\/nar\/gky1031","volume":"47","author":"PJ Volders","year":"2019","unstructured":"Volders PJ, Anckaert J, Verheggen K et al. (2019) LNCipedia 5: towards a reference set of human long non-coding RNAs. Nucleic Acids Res 47(D1):D135\u2013D139. https:\/\/doi.org\/10.1093\/nar\/gky1031","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"3_CR11","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1093\/nar\/gks296","volume":"40","author":"VA Moran","year":"2012","unstructured":"Moran VA, Perera RJ, Khalil AM (2012) Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 40(14):6391\u20136400","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"L-L Chen","year":"2016","unstructured":"Chen L-L (2016) Linking long noncoding RNA localization and function. Trends Biochem Sci 41(9):761\u2013772","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"3_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0586-4","volume":"16","author":"MN Cabili","year":"2015","unstructured":"Cabili MN, Dunagin MC, McClanahan PD et al. (2015) Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol 16(1):20","journal-title":"Genome Biol"},{"issue":"1","key":"3_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-1-r6","volume":"15","author":"S van Heesch","year":"2014","unstructured":"van Heesch S, van Iterson M, Jacobi J et al. (2014) Extensive localization of long non-coding RNAs to the cytosol and mono-and polyribosomal complexes. Genome Biol 15(1):R6","journal-title":"Genome Biol"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.29245\/2572-9411\/2016\/3.1066","volume":"1","author":"KA Lennox","year":"2016","unstructured":"Lennox KA, Behlke MA (2016) Mini-review: current strategies to knockdown long non-coding RNAs. J Rare Dis Res Treat 1:66\u201370","journal-title":"J Rare Dis Res Treat"},{"issue":"2","key":"3_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/nar\/gkv1206","volume":"44","author":"KA Lennox","year":"2015","unstructured":"Lennox KA, Behlke MA (2015) Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res 44(2):863\u2013877","journal-title":"Nucleic Acids Res"},{"issue":"7\u20138","key":"3_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00335-017-9686-7","volume":"28","author":"P Szafranski","year":"2017","unstructured":"Szafranski P, Karolak JA, Lanza D et al. (2017) CRISPR\/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region. Mamm Genome 28(7\u20138):275\u2013282","journal-title":"Mamm Genome"},{"issue":"1","key":"3_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/15476286.2017.1391443","volume":"15","author":"J Yang","year":"2018","unstructured":"Yang J, Meng X, Pan J et al. (2018) CRISPR\/Cas9-mediated non-coding RNA editing in human cancers. RNA Biol 15(1):35\u201343","journal-title":"RNA Biol"},{"issue":"1","key":"3_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-2086-z","volume":"16","author":"E Aparicio-Prat","year":"2015","unstructured":"Aparicio-Prat E, Arnan C, Sala I et al. (2015) DECKO: single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genom 16(1):846","journal-title":"BMC Genom"},{"key":"3_CR20","doi-asserted-by":"publisher","unstructured":"Gutschner T, (2015) Silencing long noncoding RNAs with genome-editing tools. In: Pruett-Miller SM (Ed.) Methods in molecular biology. Clifton, N.J., 1239: 241\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-1862-1_13","DOI":"10.1007\/978-1-4939-1862-1_13"},{"key":"3_CR21","first-page":"1","volume":"2","author":"P Koirala","year":"2016","unstructured":"Koirala P, Zou D-H, Mo Y-Y (2016) Long non-coding RNAs as key regulators of cancer metastasis. J Cancer Metastasis Treat 2:1\u201310","journal-title":"J Cancer Metastasis Treat"},{"issue":"6","key":"3_CR22","first-page":"371","volume":"34","author":"M Salehi","year":"2019","unstructured":"Salehi M, Sharifi M, Bagheri M (2019) Knockdown of long non-coding RNA plasmacytoma variant translocation 1 with antisense locked nucleic acid GapmeRs exerts tumor-suppressive functions in human acute erythroleukemia cells through downregulation of C-MYC expression. Cancer Biother Radiopharm 34(6):371\u2013379","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"3_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-5793(87)80171-0","volume":"215","author":"H Inoue","year":"1987","unstructured":"Inoue H, Hayase Y, Iwai S et al. (1987) Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett 215(2):327\u2013330. https:\/\/doi.org\/10.1016\/0014-5793(87)80171-0","journal-title":"FEBS Lett"},{"issue":"4","key":"3_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/00063030-200721040-00004","volume":"21","author":"A Gr\u00dcnweiler","year":"2007","unstructured":"Gr\u00fcnweller A, Hartmann RK (2007) Locked nucleic acid oligonucleotides. BioDrugs 21(4):235\u2013243","journal-title":"BioDrugs"},{"key":"3_CR25","volume-title":"Royal Society of Chemistry","author":"MJ Gait","year":"2019","unstructured":"Gait MJ, Agrawal S (2019) Advances in nucleic acid therapeutics, Royal Society of Chemistry, 1st edn. Cambridge, UK, vol 68","edition":"1st edn"},{"issue":"24","key":"3_CR26","doi-asserted-by":"publisher","first-page":"11535","DOI":"10.1073\/pnas.88.24.11535","volume":"88","author":"H Nakamura","year":"1991","unstructured":"Nakamura H, Oda Y, Iwai S et al. (1991) How does RNase H recognize a DNA. RNA hybrid?. Proc Natl Acad Sci 88(24):11535\u201311539","journal-title":"Proc Natl Acad Sci"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1038\/mtna.2012.34","volume":"1","author":"PP Seth","year":"2012","unstructured":"Seth PP, Jazayeri A, Yu J et al. (2012) Structure activity relationships of \u03b1-L-LNA modified phosphorothioate gapmer antisense oligonucleotides in animals. Mol Ther-Nucleic Acids 1:e47","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"8","key":"3_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/hum.2015.070","volume":"26","author":"KE Lundin","year":"2015","unstructured":"Lundin KE, Gissberg O, Smith CI (2015) Oligonucleotide therapies: the past and the present. Hum Gene Ther 26(8):475\u2013485. https:\/\/doi.org\/10.1089\/hum.2015.070","journal-title":"Hum Gene Ther"},{"issue":"3","key":"3_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/jpm3030144","volume":"3","author":"JJ Lee","year":"2013","unstructured":"Lee JJ, Yokota T (2013) Antisense therapy in neurology. J Pers Med 3(3):144\u2013176. https:\/\/doi.org\/10.3390\/jpm3030144","journal-title":"J Pers Med"},{"issue":"3","key":"3_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR (2017) Non-coding RNAs as drug targets. Nat Rev Drug Discovery 16(3):167","journal-title":"Nat Rev Drug Discovery"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/9780470697047.ch17","volume-title":"In: Anticancer Therapeutics","author":"H Khan","year":"2008","unstructured":"Khan, H, Missailidis, S, 2008. Antisense agents, In: Anticancer Therapeutics pp. 317\u2013330"},{"issue":"6","key":"3_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","volume":"37","author":"W Shen","year":"2019","unstructured":"Shen W, De Hoyos CL, Migawa MT, et al. (2019) Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat Biotechnol 37(6):640\u2013650.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/genes10050363","volume":"10","author":"S Naessens","year":"2019","unstructured":"Naessens S, Ruysschaert L, Lefever S et al. (2019) Antisense oligonucleotide-based downregulation of the G56R pathogenic variant causing NR2E3-associated autosomal dominant retinitis pigmentosa. Genes 10(5):363","journal-title":"Genes"},{"key":"3_CR34","doi-asserted-by":"crossref","unstructured":"Yoshida T, Naito Y, Yasuhara H et al (2019) Evaluation of off-target effects of gapmer antisense oligonucleotides using human cells. Genes Cells 24(12):827\u2013835","DOI":"10.1111\/gtc.12730"},{"issue":"1","key":"3_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-4608(01)00634-3","volume":"133","author":"L Pibouin","year":"2002","unstructured":"Pibouin L, Villaudy J, Ferbus D et al. (2002) Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 133(1):55\u201360","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"3_CR36","first-page":"545","volume":"22","author":"K Dhuri","year":"2023","unstructured":"Dhuri K, Dowdy SF, Roberts TC (2023) RNA therapeutics: chemistry, delivery, and clinical applications. Nat Rev Drug Discovery 22(7):545\u2013566","journal-title":"Nat Rev Drug Discovery"},{"issue":"13","key":"3_CR37","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1093\/nar\/gkg580","volume":"31","author":"N Tolstrup","year":"2003","unstructured":"Tolstrup N, Nielsen PS, Kolberg JG et al. (2003) OligoDesign: Optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling. Nucleic Acids Res 31(13):3758\u20133762","journal-title":"Nucleic Acids Res"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-429-6_1","volume":"453","author":"NR Markham","year":"2008","unstructured":"Markham NR, Zuker M (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol 453:3\u201331. https:\/\/doi.org\/10.1007\/978-1-60327-429-6_1","journal-title":"Methods Mol Biol"},{"key":"3_CR39","doi-asserted-by":"publisher","unstructured":"Paz I, Kosti I, Ares M Jr et al (2014) RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res 42(Web Server issue):W361\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gku406","DOI":"10.1093\/nar\/gku406"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/mtna.2013.72","volume":"3","author":"L Pedersen","year":"2014","unstructured":"Pedersen L, Hagedorn PH, Lindholm MW et al. (2014) A kinetic model explains why shorter and less affine enzyme-recruiting oligonucleotides can be more potent. Mol Ther Nucleic Acids 3:e149. https:\/\/doi.org\/10.1038\/mtna.2013.72","journal-title":"Mol Ther Nucleic Acids"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-071720-022934","volume":"90","author":"KM Weeks","year":"2021","unstructured":"Weeks KM (2021) Advances in SHAPE-directed RNA structure analysis. Annu Rev Biochem 90:295\u2013320.\u2002https:\/\/doi.org\/10.1146\/annurev-biochem-071720-022934","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"3_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Non-coding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 20(8):629\u2013651","journal-title":"Nat Rev Drug Discov"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2018.03.009","volume":"11","author":"PM Moreno","year":"2018","unstructured":"Moreno PM, Ferreira AR, Salvador D et al. (2018) Hydrogel-assisted antisense LNA gapmer delivery for in situ gene silencing in spinal cord injury. Mol Ther-Nucleic Acids 11:393\u2013406","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"3","key":"3_CR44","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/nar\/gkt930","volume":"42","author":"S He","year":"2014","unstructured":"He S, Li Z, Liu Y et al. (2014) Long non-coding RNA U81 directs MyoD binding to target promoters and controls myoblast differentiation. Nucleic Acids Res 42(3):1623\u20131638. https:\/\/doi.org\/10.1093\/nar\/gkt930","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3_CR45","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/nar\/gkx1179","volume":"46","author":"JM Engreitz","year":"2018","unstructured":"Engreitz JM, Lander ES, Guttman M (2018) RNA-RNA interactions enable specific targeting of noncoding RNAs to chromatin. Nucleic Acids Res 46(3):1438\u20131452. https:\/\/doi.org\/10.1093\/nar\/gkx1179","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/genes8080207","volume":"8","author":"F Leti","year":"2017","unstructured":"Leti F, DiStefano J (2017) Long non-coding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes 8(8):207","journal-title":"Genes"},{"issue":"5","key":"3_CR47","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.molcel.2020.02.014","volume":"77","author":"TR Cech","year":"2020","unstructured":"Cech TR, Steitz JA (2020) The intertwined roles of RNA and protein in mechanism and function. Mol Cell 77(5):929\u2013931. https:\/\/doi.org\/10.1016\/j.molcel.2020.02.014","journal-title":"Mol Cell"},{"issue":"5","key":"3_CR48","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.drudis.2020.03.011","volume":"25","author":"AM Yu","year":"2020","unstructured":"Yu AM, Choi YJ, Tu MJ (2020) RNA drugs and RNA targets for small molecules: principles, progress, and challenges. Drug Discov Today 25(5):886\u2013891. https:\/\/doi.org\/10.1016\/j.drudis.2020.03.011","journal-title":"Drug Discov Today"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4939-8651-4_4","volume-title":"In: Exon skipping and inclusion therapies","author":"K Goodkey","year":"2018","unstructured":"Goodkey, K, Aslesh, T, Maruyama, R, et al. (2018) Nusinersen in the treatment of spinal muscular atrophy, In: Exon skipping and inclusion therapies. Springer, Clifton, N.J., pp. 69\u201376, https:\/\/doi.org\/10.1007\/978-1-4939-8651-4_4"},{"issue":"7","key":"3_CR50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00109-013-1028-y","volume":"91","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Diederichs S (2013) MALAT1\u2014a paradigm for long non-coding RNA function in cancer. J Mol Med 91(7):791\u2013801","journal-title":"J Mol Med"},{"issue":"10","key":"3_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.466","volume":"5","author":"J Liu","year":"2014","unstructured":"Liu J, Yao J, Li X et al. (2014) Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5(10):e1506","journal-title":"Cell Death Dis"},{"issue":"3","key":"3_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL (2018) Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med 24(3):257\u2013277","journal-title":"Trends Mol Med"},{"issue":"9","key":"3_CR53","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, Stamato MA, Juli G et al. (2018) Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia 32(9):1948","journal-title":"Leukemia"},{"issue":"1","key":"3_CR54","first-page":"e00596","volume":"4","author":"Daniela D\u2019Angelo","year":"2013","unstructured":"D'Angelo D, Mussnich P, Sepe R et al. (2015) RPSAP52, an antisense transcript of the HMGA2 gene, is overexpressed in pituitary tumors and acts as a miRNA sponge promoting cell proliferation. Oncotarget 6(7):5541\u20135555","journal-title":"mBio"},{"issue":"13","key":"3_CR55","first-page":"2652","volume":"79","author":"AS Castillo","year":"2019","unstructured":"Castillo AS, Mateos CO, Riera MS et al. (2019) Non-coding RNAs as key players for understanding oncogenic pathways in ovarian cancer: Studying new therapeutic strategies. AACR Cancer Research 79(13):2652.","journal-title":"AACR Cancer Research"},{"key":"3_CR56","first-page":"106","volume":"515","author":"Y Gao","year":"2021","unstructured":"Gao Y et al. (2021) The roles of non-coding RNAs in the chemoresistance of ovarian cancer. Cancer Lett 515:106\u2013117","journal-title":"Cancer Lett"},{"issue":"8","key":"3_CR57","doi-asserted-by":"publisher","first-page":"E1509","DOI":"10.1073\/pnas.1616521114","volume":"114","author":"CJ Woo","year":"2017","unstructured":"Woo CJ, Maier VK, Davey R et al. (2017) Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Proc Natl Acad Sci 114(8):E1509\u2013E1518","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke ST, Baker BF, Crooke RM, Liang XH (2021) Antisense drug discovery and development technology considered in a modern context. Nat Rev Drug Discov 20(6):427\u2013453","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3_CR59","first-page":"335","volume":"27","author":"M Nizzardo","year":"2021","unstructured":"Nizzardo M, Simone C, et al. (2021) Modulation of SMN2 expression by ASOs and alternative approaches: progress and prospects. Trends Mol Med 27(4):335\u2013351.","journal-title":"Trends Mol Med"},{"issue":"326","key":"3_CR60","doi-asserted-by":"publisher","first-page":"326ra322","DOI":"10.1126\/scitranslmed.aaf1475","volume":"8","author":"J Viereck","year":"2016","unstructured":"Viereck J, Kumarswamy R, Foinquinos A et al. (2016) Long non-coding RNA chast promotes cardiac remodeling. Sci Transl Med 8(326):326ra322\u2013326ra322","journal-title":"Sci Transl Med"},{"issue":"1","key":"3_CR61","first-page":"1","volume":"115","author":"J Viereck","year":"2020","unstructured":"Viereck J, Thum T (2020) Circulating microRNAs as biomarkers of cardiovascular disease. Basic Res Cardiol 115(1):1\u201312","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"3_CR62","volume":"132","author":"C B\u00e4r","year":"2022","unstructured":"B\u00e4r C, Thum T (2022) Non-coding RNAs in cardiac remodeling and heart failure: structural and mechanistic insights. J Clin Invest 132(2), e155747.","journal-title":"J Clin Invest"},{"issue":"8","key":"3_CR63","first-page":"1006","volume":"126","author":"J Fiedler","year":"2020","unstructured":"Fiedler J, Thum T (2020) LncRNAs in cardiovascular diseases. Circ Res 126(8):1006\u20131023","journal-title":"Circ Res"},{"issue":"560","key":"3_CR64","first-page":"eaaw6595","volume":"12","author":"M Ponnusamy","year":"2020","unstructured":"Ponnusamy M et al. (2020) The lncRNA wisper is a pro-fibrotic regulator of the cardiac extracellular matrix. Sci Transl Med 12(560):eaaw6595","journal-title":"Sci Transl Med"},{"issue":"2","key":"3_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1164\/rccm.201812-2313ED","volume":"200","author":"D Jiang","year":"2019","unstructured":"Jiang D, Liang J (2019) A lncRNA links TGF-\u03b2 signaling in lung fibrosis. Am J Respir Crit Care Med (JA) 200(2):123\u2013125.","journal-title":"Am J Respir Crit Care Med (JA)"},{"issue":"17","key":"3_CR66","first-page":"8343","volume":"11","author":"J Liang","year":"2021","unstructured":"Liang J et al. (2021) Silencing of lncRNA H19 protects against bleomycin-induced pulmonary fibrosis by regulating the miR-196a\/ET-1 axis. Theranostics 11(17):8343\u20138359","journal-title":"Theranostics"},{"issue":"1","key":"3_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1349-7006.2010.01737.x","volume":"102","author":"S Chung","year":"2011","unstructured":"Chung S, Nakagawa H, Uemura M et al. (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 102(1):245\u2013252","journal-title":"Cancer Sci"},{"issue":"19","key":"3_CR68","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1158\/1078-0432.CCR-06-2882","volume":"13","author":"Y Guan","year":"2007","unstructured":"Guan Y, Kuo W-L, Stilwell JL et al. (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13(19):5745\u20135755","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3_CR69","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","volume":"132","author":"K Panzitt","year":"2007","unstructured":"Panzitt K, Tschernatsch MM, Guelly C et al. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132(1):330\u2013342","journal-title":"Gastroenterology"},{"issue":"6","key":"3_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF00968788","volume":"17","author":"W Lukiw","year":"1992","unstructured":"Lukiw W, Handley P, Wong L et al. (1992) BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 17(6):591\u2013597","journal-title":"Neurochem Res"},{"key":"3_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep34862","volume":"6","author":"M Nair","year":"2016","unstructured":"Nair M, Sagar V, Pilakka-Kanthikeel S (2016) Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection. Sci Rep 6: 34862","journal-title":"Sci Rep"},{"issue":"12","key":"3_CR72","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10038-006-0070-9","volume":"51","author":"N Ishii","year":"2006","unstructured":"Ishii N, Ozaki K, Sato H et al. (2006) Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 51(12):1087","journal-title":"J Hum Genet"},{"issue":"1","key":"3_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s43856-023-00419-1","volume":"7","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhang X, Liu Y et al. (2024) LncRNA NEAT1 promotes neuroinflammation in Parkinson\u2019s disease by regulating \u03b1-synuclein aggregation via the miR-127-5p\/NLRP3 pathway. Commun Biol 7(1):74. https:\/\/doi.org\/10.1038\/s43856-023-00419-1","journal-title":"Commun Biol"},{"issue":"11","key":"3_CR74","first-page":"847","volume":"21","author":"DR Scoles","year":"2022","unstructured":"Scoles DR, Mehta S, Hart MP (2022) Delivery strategies for oligonucleotide therapeutics outside the liver. Nat Rev Drug Discov 21(11):847\u2013866","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"3_CR75","first-page":"e2463","volume":"101","author":"L Laux","year":"2023","unstructured":"Laux L et al. (2023) STK-001, an Antisense oligonucleotide, for the treatment of dravet syndrome: an open-label, repeated-dose study. Neurology 101(24):e2463\u2013e2474","journal-title":"Neurology"},{"issue":"16","key":"3_CR76","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.1613203114","volume":"114","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y, Nakamura A, Nagata T et al. (2017) Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 114(16):4213\u20134218. https:\/\/doi.org\/10.1073\/pnas.1613203114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR77","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al. (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci U S A 102(1):198\u2013203. https:\/\/doi.org\/10.1073\/pnas.0406700102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR78","doi-asserted-by":"publisher","unstructured":"Ezzat K, Aoki Y, Koo T et al (2015) Self-assembly into nanoparticles is essential for receptor mediated uptake of therapeutic antisense oligonucleotides. Nano Lett 15(7). https:\/\/doi.org\/10.1021\/acs.nanolett.5b00490","DOI":"10.1021\/acs.nanolett.5b00490"},{"issue":"10","key":"3_CR82","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1023\/A:1016260110049","volume":"12","author":"I Walker","year":"1995","unstructured":"Walker I, Irwin WJ, Akhtar S (1995) Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates. Pharm Res 12(10):1548\u20131553","journal-title":"Pharm Res"},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1038\/mtna.2014.76","volume":"4","author":"Y Echigoya","year":"2015","unstructured":"Echigoya Y, Aoki Y, Miskew B et al. (2015) Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45\u201355 with a cocktail of vivo-morpholinos in mdx52 mice. Mol Ther Nucleic Acids 4:e225. https:\/\/doi.org\/10.1038\/mtna.2014.76","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Methods in Molecular Biology","Gapmers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5476-7_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:04:12Z","timestamp":1790769852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5476-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071654750","9781071654767"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5476-7_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}